A UK life sciences startup using AI to develop new medicines faster to treat diseases has raised $140m in funding, in an investment round featuring AI powerhouses Nvidia and new investor Anthropic. Basecamp Research, founded in 2019, is a London-based startup that leverages AI and biodiversity data to design the next generation of treatments aimed at treating cancer, autoimmune and other diseases. The $140m Series C round - which is large for a Series C- was led by S32, the California venture fi...